Influenza Vaccine

Japanese biotech adopts MES at recombinant flu vaccine plant

Japanese biotech adopts MES at recombinant flu vaccine plant

By Zachary Brennan

Japanese biotech company Unigen has implemented in only four months Werum's PAS-X Manufacturing Execution System (MES), which can help optimize production output at the world’s largest plant for the contract manufacturing of recombinant flu vaccines.

Novartis comments on $490m cell-culture vaccine contract

Novartis comments on $490m cell-culture vaccine contract

By Gareth Macdonald

Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers